Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
This study is ongoing, but not recruiting participants.
Sponsor:
Fox Chase Cancer Center
Collaborators:
Genentech
OSI Pharmaceuticals
Information provided by:
Fox Chase Cancer Center
ClinicalTrials.gov Identifier:
NCT00553800
First received: November 5, 2007
Last updated: March 1, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |